BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9461588)

  • 1. Modification of phosphatidylinositol 3-kinase SH2 domain binding properties by Abl- or Lck-mediated tyrosine phosphorylation at Tyr-688.
    von Willebrand M; Williams S; Saxena M; Gilman J; Tailor P; Jascur T; Amarante-Mendes GP; Green DR; Mustelin T
    J Biol Chem; 1998 Feb; 273(7):3994-4000. PubMed ID: 9461588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.
    Cuevas B; Lu Y; Watt S; Kumar R; Zhang J; Siminovitch KA; Mills GB
    J Biol Chem; 1999 Sep; 274(39):27583-9. PubMed ID: 10488096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Lck SH2 domain by tyrosine phosphorylation.
    Couture C; Songyang Z; Jascur T; Williams S; Tailor P; Cantley LC; Mustelin T
    J Biol Chem; 1996 Oct; 271(40):24880-4. PubMed ID: 8798764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl.
    Jain SK; Susa M; Keeler ML; Carlesso N; Druker B; Varticovski L
    Blood; 1996 Sep; 88(5):1542-50. PubMed ID: 8781408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells.
    Harrison-Findik D; Susa M; Varticovski L
    Oncogene; 1995 Apr; 10(7):1385-91. PubMed ID: 7537361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
    Dutartre H; Harris M; Olive D; Collette Y
    Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the Grb2- and phosphatidylinositol 3-kinase p85-binding p36/38 by Syk in Lck-negative T cells.
    von Willebrand M; Williams S; Tailor P; Mustelin T
    Cell Signal; 1998 Jun; 10(6):407-13. PubMed ID: 9720763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling.
    Nika K; Tautz L; Arimura Y; Vang T; Williams S; Mustelin T
    J Biol Chem; 2007 Dec; 282(49):36000-9. PubMed ID: 17897955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase is required for CD28 but not CD3 regulation of the TEC family tyrosine kinase EMT/ITK/TSK: functional and physical interaction of EMT with phosphatidylinositol 3-kinase.
    Lu Y; Cuevas B; Gibson S; Khan H; LaPushin R; Imboden J; Mills GB
    J Immunol; 1998 Nov; 161(10):5404-12. PubMed ID: 9820515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
    Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation of the p85 subunit of phosphatidylinositol 3-kinase correlates with high proliferation rates in sublines derived from the Jurkat leukemia.
    Martínez-Lorenzo MJ; Anel A; Monleón I; Sierra JJ; Piñeiro A; Naval J; Alava MA
    Int J Biochem Cell Biol; 2000 Apr; 32(4):435-45. PubMed ID: 10762069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.
    Ren SY; Bolton E; Mohi MG; Morrione A; Neel BG; Skorski T
    Mol Cell Biol; 2005 Sep; 25(18):8001-8. PubMed ID: 16135792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
    Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
    J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paxillin phosphorylation and association with Lck and Pyk2 in anti-CD3- or anti-CD45-stimulated T cells.
    Ostergaard HL; Lou O; Arendt CW; Berg NN
    J Biol Chem; 1998 Mar; 273(10):5692-6. PubMed ID: 9488700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Lck function through multisite docking to T cell-specific adapter protein.
    Granum S; Andersen TC; Sørlie M; Jørgensen M; Koll L; Berge T; Lea T; Fleckenstein B; Spurkland A; Sundvold-Gjerstad V
    J Biol Chem; 2008 Aug; 283(32):21909-19. PubMed ID: 18541536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of halogenation on tyrosine phosphorylation and peptide binding to the SRC homology 2 domain of lymphocyte-specific protein tyrosine kinase.
    Okamura T; Kikuchi T; Nodaira M; Odaka K; Fukushi K; Irie T
    Biol Pharm Bull; 2012; 35(3):433-7. PubMed ID: 22382333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.